208 related articles for article (PubMed ID: 24218087)
1. Mutations in MAPT give rise to aneuploidy in animal models of tauopathy.
Rossi G; Conconi D; Panzeri E; Paoletta L; Piccoli E; Ferretti MG; Mangieri M; Ruggerone M; Dalprà L; Tagliavini F
Neurogenetics; 2014 Mar; 15(1):31-40. PubMed ID: 24218087
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of Human Mutant Tau Prion Formation in the Brains of 2 Transgenic Mouse Lines.
Woerman AL; Patel S; Kazmi SA; Oehler A; Freyman Y; Espiritu L; Cotter R; Castaneda JA; Olson SH; Prusiner SB
JAMA Neurol; 2017 Dec; 74(12):1464-1472. PubMed ID: 29059326
[TBL] [Abstract][Full Text] [Related]
3. Mitotic defects lead to neuronal aneuploidy and apoptosis in frontotemporal lobar degeneration caused by MAPT mutations.
Caneus J; Granic A; Rademakers R; Dickson DW; Coughlan CM; Chial HJ; Potter H
Mol Biol Cell; 2018 Mar; 29(5):575-586. PubMed ID: 29282277
[TBL] [Abstract][Full Text] [Related]
4. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
[TBL] [Abstract][Full Text] [Related]
5. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1.
Asai H; Ikezu S; Woodbury ME; Yonemoto GM; Cui L; Ikezu T
Am J Pathol; 2014 Mar; 184(3):808-18. PubMed ID: 24418258
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
[TBL] [Abstract][Full Text] [Related]
7. Behavioural Functions and Cerebral Blood Flow in a P301S Tauopathy Mouse Model: A Time-Course Study.
Ahmad F; Mein H; Jing Y; Zhang H; Liu P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575885
[TBL] [Abstract][Full Text] [Related]
8. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
Strang KH; Golde TE; Giasson BI
Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
[TBL] [Abstract][Full Text] [Related]
9. BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT
Perez-Garcia G; Bicak M; Haure-Mirande JV; Perez GM; Otero-Pagan A; Gama Sosa MA; De Gasperi R; Sano M; Barlow C; Gage FH; Readhead B; Ehrlich ME; Gandy S; Elder GA
Neurosci Lett; 2023 Feb; 797():137080. PubMed ID: 36657633
[TBL] [Abstract][Full Text] [Related]
10. Picalm reduction exacerbates tau pathology in a murine tauopathy model.
Ando K; De Decker R; Vergara C; Yilmaz Z; Mansour S; Suain V; Sleegers K; de Fisenne MA; Houben S; Potier MC; Duyckaerts C; Watanabe T; Buée L; Leroy K; Brion JP
Acta Neuropathol; 2020 Apr; 139(4):773-789. PubMed ID: 31925534
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitor of tau self-association in a mouse model of tauopathy: A preventive study in P301L tau JNPL3 mice.
Davidowitz EJ; Lopez P; Jimenez H; Adrien L; Davies P; Moe JG
PLoS One; 2023; 18(8):e0286523. PubMed ID: 37556474
[TBL] [Abstract][Full Text] [Related]
12. Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions.
Sidoryk-Wegrzynowicz M; Gerber YN; Ries M; Sastre M; Tolkovsky AM; Spillantini MG
Acta Neuropathol Commun; 2017 Nov; 5(1):89. PubMed ID: 29187256
[TBL] [Abstract][Full Text] [Related]
13. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
Rademakers R; Cruts M; van Broeckhoven C
Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
[TBL] [Abstract][Full Text] [Related]
14. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
15. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.
Kraemer BC; Zhang B; Leverenz JB; Thomas JH; Trojanowski JQ; Schellenberg GD
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9980-5. PubMed ID: 12872001
[TBL] [Abstract][Full Text] [Related]
16. Combining P301L and S320F tau variants produces a novel accelerated model of tauopathy.
Koller EJ; Gonzalez De La Cruz E; Machula T; Ibanez KR; Lin WL; Williams T; Riffe CJ; Ryu D; Strang KH; Liu X; Janus C; Golde TE; Dickson D; Giasson BI; Chakrabarty P
Hum Mol Genet; 2019 Oct; 28(19):3255-3269. PubMed ID: 31261380
[TBL] [Abstract][Full Text] [Related]
17. Cryo-EM structures of tau filaments from the brains of mice transgenic for human mutant P301S Tau.
Schweighauser M; Murzin AG; Macdonald J; Lavenir I; Crowther RA; Scheres SHW; Goedert M
Acta Neuropathol Commun; 2023 Oct; 11(1):160. PubMed ID: 37798679
[TBL] [Abstract][Full Text] [Related]
18. Mutations in MAPT gene cause chromosome instability and introduce copy number variations widely in the genome.
Rossi G; Conconi D; Panzeri E; Redaelli S; Piccoli E; Paoletta L; Dalprà L; Tagliavini F
J Alzheimers Dis; 2013; 33(4):969-82. PubMed ID: 23047372
[TBL] [Abstract][Full Text] [Related]
19. Analysis of tauopathies with transgenic mice.
Hutton M; Lewis J; Dickson D; Yen SH; McGowan E
Trends Mol Med; 2001 Oct; 7(10):467-70. PubMed ID: 11597522
[TBL] [Abstract][Full Text] [Related]
20. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
